Gene Ontology annotation through association of InterPro records with GO terms
Manual transfer of experimentally-verified manual GO annotation data to orthologs by curator judgment of sequence similarity
Annotation inferences using phylogenetic trees
Gene Ontology annotation based on UniProtKB/Swiss-Prot Subcellular Location vocabulary mapping, accompanied by conservative changes to GO terms applied by UniProt
Gene Ontology annotation based on curation of immunofluorescence data
Automatic transfer of experimentally verified manual GO annotation data to orthologs using Ensembl Compara
Combined Automated Annotation using Multiple IEA Methods
Frataxin interacts functionally with mitochondrial electron transport chain proteins.
-
Frataxin physically interacts with succinate dehydrogenase complex subunits SDHA and SDHB in both yeast and humans, suggesting a role for frataxin in the mitochondrial electron transport chain.
"We also demonstrate a physical interaction between human frataxin and human succinate dehydrogenase complex subunits, suggesting also a key role of frataxin in the mitochondrial electron transport chain in humans"
Leigh syndrome caused by mutations in the flavoprotein (Fp) subunit of succinate dehydrogenase (SDHA).
-
Compound heterozygous SDHA mutations (W119X nonsense in exon 4 and A83V missense in exon 3) cause Leigh syndrome with severe complex II deficiency demonstrated by biochemical measurement in skeletal muscle.
"Biochemical measurement of skeletal muscle showed a severe decrease in mitochondrial complex II. Sequencing of SDHA revealed compound heterozygosity for a nonsense mutation in exon 4 (W119X) and a missense mutation in exon 3 (A83V), both absent in normal controls."
-
Genetic heterogeneity exists for isolated complex II deficiency; six additional patients with Leigh or Leigh-like syndrome and complex II deficiency did not harbor SDHA mutations.
"In six additional patients--five with Leigh or Leigh-like syndrome and one with neuropathy and ataxia associated with isolated deficiency of complex II--mutations in SDHA were not detected, indicating genetic heterogeneity."
Coupling mitochondrial respiratory chain to cell death: an essential role of mitochondrial complex I in the interferon-beta and retinoic acid-induced cancer cell death.
-
IFN-beta/RA upregulates expression of mitochondrial respiratory chain complex subunits. Study is primarily about Complex I (GRIM-19, NDUFS3); SDHA relevance is indirect, as the study demonstrates that MRC upregulation drives ROS-mediated cancer cell death.
"We found that IFN-beta/RA upregulates the expression of MRC complex subunits. Mitochondrial-nuclear translocation of these subunits was not observed, but overproduction of reactive oxygen species (ROS), which causes loss of mitochondrial function, was detected upon IFN-beta/RA treatment."
Large-scale mapping of human protein-protein interactions by mass spectrometry.
SDH5, a gene required for flavination of succinate dehydrogenase, is mutated in paraganglioma.
-
SDH5/SDHAF2 physically interacts with the catalytic subunit of the SDH complex (Sdh1 in yeast, SDHA in humans) and is required for covalent flavination, i.e. incorporation of the FAD cofactor into the flavoprotein subunit.
"Both yeast and human Sdh5 interact with the catalytic subunit of the succinate dehydrogenase (SDH) complex, a component of both the electron transport chain and the tricarboxylic acid cycle. Sdh5 is required for SDH-dependent respiration and for Sdh1 flavination (incorporation of the flavin adenine dinucleotide cofactor)."
-
Germline loss-of-function mutations in human SDH5/SDHAF2 segregate with hereditary paraganglioma, linking SDHA flavination assembly to tumor suppression.
"Germline loss-of-function mutations in the human SDH5 gene, located on chromosome 11q13.1, segregate with disease in a family with hereditary paraganglioma, a neuroendocrine tumor previously linked to mutations in genes encoding SDH subunits."
LC-MS/MS as an alternative for SDS-PAGE in blue native analysis of protein complexes.
The mitochondrial chaperone TRAP1 promotes neoplastic growth by inhibiting succinate dehydrogenase.
-
TRAP1 physically interacts with SDH complex II, confirmed by co-immunoprecipitation, BN-PAGE, and chemical crosslinking. Two distinct TRAP1/SDH complexes are formed in mitochondria.
"We confirmed the interaction between TRAP1 and complex II/SDH through further approaches, including (1) immunoprecipitation, finding coimmunoprecipitation (coIP) of TRAP1 with SDH and vice versa (Figure 3C), and (2) mitochondrial protein crosslinking with dimethyl 3,3′-dithiobis-propionimidate (DTBP), a homobifunctional compound that reacts with the primary amines of two interacting proteins at an average distance of about 8 Å (Giorgio et al., 2009), followed by TRAP1 immunoprecipitation in order to determine whether TRAP1 and SDH are closely associated. We found that two TRAP1/SDH complexes are formed in mitochondria (Figure 3D)."
-
TRAP1 knockdown increases SQR enzymatic activity without affecting complex II protein levels. TRAP1 re-expression restores inhibition, and the Hsp90 inhibitor 17-AAG reverses TRAP1-mediated SDH inhibition, demonstrating the inhibition is reversible.
"We found that SQR enzymatic activity was increased in mitochondria from shTRAP1 cells relative to those derived from control cells (Figures 4A, S2A, and S2B). TRAP1 did not affect either the cytochrome oxidase enzymatic activity of complex IV (Figure S2C) or complex II protein levels (Figure S2D) or mitochondrial mass (Figure S2E)."
-
TRAP1-mediated SDH inhibition causes intracellular succinate accumulation and pseudohypoxic HIF1a stabilization (independent of oxygen deprivation), establishing a mechanism for the Warburg effect in tumors via SDH regulation.
"We observe that TRAP1-mediated inhibition of SDH limits the maximal rate of respiration and leads to succinate accumulation followed by HIF1α, but not HIF2α, stabilization. Remarkably, the membrane-permeable succinate analog dimethyl succinate could both elicit HIF1α stabilization and rescue the tumorigenic phenotype of shTRAP1 cells, highlighting the mechanistic connection between TRAP1-dependent succinate accumulation and HIF1α-dependent tumor formation."
-
The SDH inhibitor 3-nitropropionic acid (3-NP) inactivates SDH by covalent binding with an Arg residue in the catalytic core of SDHA, confirming SDHA as the site of catalytic activity in Complex II.
"A low concentration of the ETC complex II inhibitors 3-nitropropionic acid (3-NP), which inactivates SDH after covalent binding with an Arg residue in the catalytic core of SDHA (Huang et al., 2006), or thenoyltrifluoroacetone (TTFA), which blocks electron transfer from succinate to coenzyme Q at the quinone-binding site in subunits B and D (Huang et al., 2006), inhibited OCR in shTRAP1 cells but were inactive in the presence of TRAP1 (Figures S4B and S4C), paralleling the downmodulation of the SQR activity induced by 3-NP only in TRAP1-expressing mitochondria (Figure 5E)."
Cochaperone binding to LYR motifs confers specificity of iron sulfur cluster delivery.
SDHA mutations causing a multisystem mitochondrial disease: novel mutations and genetic overlap with hereditary tumors.
A human interactome in three quantitative dimensions organized by stoichiometries and abundances.
∆F508 CFTR interactome remodelling promotes rescue of cystic fibrosis.
Disease-Causing SDHAF1 Mutations Impair Transfer of Fe-S Clusters to SDHB.
Systematic Analysis of Human Protein Phosphatase Interactions and Dynamics.
Architecture of the human interactome defines protein communities and disease networks.
A Map of Human Mitochondrial Protein Interactions Linked to Neurodegeneration Reveals New Mechanisms of Redox Homeostasis and NF-κB Signaling.
A Proteomic Variant Approach (ProVarA) for Personalized Medicine of Inherited and Somatic Disease.
Assembly of mammalian oxidative phosphorylation complexes I-V and supercomplexes.
-
Review of OXPHOS complex assembly. Complex II (SDH) comprises SDHA, SDHB, SDHC, SDHD. Assembly involves FAD insertion into SDHA by SDHAF2, followed by SDHA-SDHB dimerization and insertion into the membrane via SDHC-SDHD.
Inhibition of calpain 1 restores plasma membrane stability to pharmacologically rescued Phe508del-CFTR variant.
Dual proteome-scale networks reveal cell-specific remodeling of the human interactome.
Quantitative high-confidence human mitochondrial proteome and its dynamics in cellular context.
CFTR interactome mapping using the mammalian membrane two-hybrid high-throughput screening system.
Structure of the human respiratory complex II.
-
Cryo-EM structure of human Complex II at 2.86A resolution showing all four subunits (SDHA, SDHB, SDHC, SDHD) with FAD, three Fe-S clusters, heme b, and ubiquinone. SDHA contains four subdomains: FAD-binding, capping, helical, and C-terminal domains. The active site for succinate-fumarate interconversion is at the interface of the FAD-binding and capping domains. Electron transfer pathway from FAD through Fe-S clusters to ubiquinone is proposed.
Mutation of a nuclear succinate dehydrogenase gene results in mitochondrial respiratory chain deficiency.
-
First identification of a nuclear gene mutation causing mitochondrial respiratory chain deficiency. Homozygous Arg554Trp mutation in SDHA causes Leigh syndrome with complex II deficiency in two siblings born to consanguineous parents.
"We now report a mutation in the nuclear-encoded flavoprotein (Fp) subunit gene of the succinate dehydrogenase (SDH) in two siblings with complex II deficiency presenting as Leigh syndrome. Both patients were homozygous for an Arg554Trp substitution in the Fp subunit. Their parents (first cousins) were heterozygous for the mutation that occurred in a conserved domain of the protein and was absent from 120 controls."
-
The deleterious effect of the Arg554Trp mutation on SDH catalytic activity was demonstrated in a yeast complementation assay using an SDH-deficient strain transformed with mutant Fp cDNA.
"The deleterious effect of the Arg to Trp substitution on the catalytic activity of SDH was observed in a SDH- yeast strain transformed with mutant Fp cDNA."
-
The Fp subunit gene is duplicated in the human genome at chromosomes 3q29 and 5p15, with only the chromosome 5 copy expressed.
"The Fp subunit gene is duplicated in the human genome (3q29; 5p15), with only the gene on chromosome 5 expressed in human-hamster somatic cell hybrids. This is the first report of a nuclear gene mutation causing a mitochondrial respiratory chain deficiency in humans."
SDH complex dehydrogenates succinate
Citric acid cycle (TCA cycle)
SDHA:SDHB binds to SDHC:SDHD
Deep research review of SDHA gene function (Falcon provider)
-
SDHA encodes the covalently flavinylated FAD-containing flavoprotein subunit of mitochondrial complex II. Its catalytic role in succinate oxidation and electron transfer to ubiquinone is conserved. SDHx genes including SDHA contribute to paraganglioma/pheochromocytoma (PPGL) genetics.
"Complex II (succinate dehydrogenase, SDH) catalyzes the oxidation of succinate to fumarate, coupling two-electron transfer via FAD and iron-sulfur centers to reduce ubiquinone to ubiquinol in the inner mitochondrial membrane"